Idamakanti, M. et al. 2025. Long Durable Response With Trastuzumab Deruxtecan Monotherapy in a Triple-Negative Metastatic Breast Cancer Patient With Human Epidermal Growth Factor Receptor 2 Mutation: A Long-Term Follow-Up and Literature Review. Journal of Medical Cases. 16, 6 (Jun. 2025), 212–221. DOI:https://doi.org/10.14740/jmc5136.